LIMIT: LongItudinal Immunology of Monkeypox InfecTion
Research type
Research Study
Full title
LIMITS: LongItudinal Monkeypox InfecTion Study Monkeypox Virus antibody versus time in those that have been infected and those that have been vaccinated.
IRAS ID
319316
Contact name
Helen Callaby
Contact email
Sponsor organisation
UKHSA
Duration of Study in the UK
0 years, 5 months, 16 days
Research summary
This protocol outlines prospective serosurveillance of confirmed PCR positive Monkeypox cases in England as well as those that have been vaccinated using Imvanex.
This study will aid understanding of the immunological response to Monkeypox infection and how antibody titres may wane over time. It may also provide insight into the protection afforded by vaccination compared with natural infection.
REC name
London - Queen Square Research Ethics Committee
REC reference
22/HRA/3321
Date of REC Opinion
3 Nov 2022
REC opinion
Further Information Favourable Opinion